يعرض 1 - 10 نتائج من 31 نتيجة بحث عن '"Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES]"', وقت الاستعلام: 1.47s تنقيح النتائج
  1. 1

    المساهمون: Institut Català de la Salut, [Søreide K] Department of Gastrointestinal Surgery, HPB Unit, Stavanger University Hospital, Stavanger, Norway. Department of Clinical Medicine, University of Bergen, Bergen, Norway. [Rangelova E] Section of Upper GI Surgery at Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden. [Dopazo C] Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Mieog S] Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands. [Stättner S] Department of General, Visceral and Vascular Surgery, Salzkammergut Klinikum, OÖG, Vöcklabruck, Austria, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  2. 2

    المساهمون: Institut Català de la Salut, [Vera R] Navarra University Hospital, Spanish Society of Medical Oncology (SEOM), Pamplona, Spain. [Ibarrola-de-Andrés C, Rodríguez-Gil Y] 12 de Octubre University Hospital, Spanish Society of Pathology (SEAP), Madrid, Spain. [Adeva J] 12 de Octubre University Hospital, Spanish Society of Medical Oncology (SEOM), Madrid, Spain. [Pérez-Rojas J] La Fe University and Polytechnic Hospital, Spanish Society of Pathology (SEAP), Valencia, Spain. [García-Alfonso P] Gregorio Marañón University Hospital, Spanish Society of Medical Oncology (SEOM), Madrid, Spain. [Macarulla T] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Society of Medical Oncology (SEOM), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: CLINICAL & TRANSLATIONAL ONCOLOGY
    r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
    instname
    Scientia

    وصف الملف: application/pdf

  3. 3

    المساهمون: Institut Català de la Salut, [de Vries EGE] Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. [Rüschoff J] Targos Molecular Pathology GmbH, Kassel, Germany. [Lolkema M] Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. [Tabernero J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVicUCC, IOB-Quiron, Barcelona, Spain. [Gianni L] Michelangelo Foundation, Milan, Italy. [Voest E] Netherlands Cancer Institute, Amsterdam, The Netherlands. Oncode Institute, Amsterdam, The Netherlands, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  4. 4

    المساهمون: Institut Català de la Salut, [Chen JW, Lof S] Amsterdam UMC, Department of Surgery, Location University of Amsterdam, Amsterdam, The Netherlands. Cancer Center Amsterdam, Amsterdam, The Netherlands. [van Ramshorst TME] Amsterdam UMC, Department of Surgery, Location University of Amsterdam, Amsterdam, The Netherlands. Cancer Center Amsterdam, Amsterdam, The Netherlands. Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy. [Al-Sarireh B] Department of Surgery, Morriston Hospital, Swansea, UK. [Bjornsson B] Department of Surgery and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. [Boggi U] Department of Surgery, University Hospital of Pisa, Pisa, Italy. [Pando E] Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  5. 5

    المساهمون: Institut Català de la Salut, [Huebner A] Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. [Black JRM] Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. [Sarno F] Peaches Biotech, Madrid, Spain. [Pazo R] Hospital Universitario Miguel Servet, Zaragoza, Spain. [Juez I] Hospital Universitario de Fuenlabrada, Madrid, Spain. [Medina L] IBIMA, Virgen de La Victoria, Malaga, Spain. [Arenillas C, Toledo RA] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. [Moreno-Cárdenas AB] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Verdaguer H, Macarulla T] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.spreadsheetml.sheet

  6. 6

    المساهمون: Institut Català de la Salut, [Bekaii-Saab T] Division of Hematology and Medical Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA. [Okusaka T] Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan. [Goldstein D] Department of Medical Oncology, Prince of Wales Hospital, Randwick, NSW, Australia. [Oh DY] Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Republic of Korea. [Ueno M] Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Kanagawa, Japan. [Ioka T] Oncology Center, Yamaguchi University Hospital, Yamaguchi, Japan. [Tabernero J] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf; Electronic-eCollection

  7. 7

    المساهمون: UAM. Departamento de Cirugía, Institut Català de la Salut, [Carrato A] Medical Oncology Department, Ramon y Cajal University Hospital, Alcalá University, IRYCIS, CIBERONC, Pancreatic Cancer Europe, Madrid, Spain. [Cerezo L] Radiation Oncology Department, La Princesa University Hospital, Madrid, Spain. [Feliu J] Medical Oncology Department, La Paz University Hospital, IdiPAZ, Cátedra UAM-AMGEN, CIBERONC, Madrid, Spain. [Macarulla T] Servei d’Oncologia Mèdica, Vall d´Hebron Hospital Universitari, Barcelona, Spain. Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Martín-Pérez E] Department of Surgery, Division of Hepatobiliopancreatic Surgery, La Princesa University Hospital, IIS La Princesa, Madrid, Spain. [Vera R] Medical Oncology Department, Complejo Hospitalario de Navarra, Navarrabiomed, IDISNA, Pamplona, Spain. [Álvarez J] Endocrinology and Nutritional Department, Príncipe de Asturias University Hospital, Alcalá University, Alcalá de Henares, Madrid, Spain. [Botella-Carretero JI] Endocrinology and Nutritional Department, CIBER of Physiology, Obesity, and Nutrition (CIBEROBN), Ramón y Cajal University Hospital, IRyCIS, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    Clinical & Translational Oncology

    وصف الملف: application/pdf

  8. 8

    المساهمون: Institut Català de la Salut, [Tempero M] Department of Medicine, University of California San Francisco, San Francisco, USA. [Oh DY] Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea. [Tabernero J, Macarulla T] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UICC, CIBERONC, Barcelona, Spain. [Reni M] Department of Radiochemotherapy, San Raffaele Hospital Scientific Institute, Milan, Italy. [Van Cutsem E] Department of Digestive Oncology, University Hospitals Gasthuisberg/Leuven & KU Leuven, Leuven, Belgium. [Hendifar A] Department of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, USA, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    مصطلحات موضوعية: 0301 basic medicine, Oncology, metastatic pancreatic adenocarcinoma, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Deoxycytidine, Tyrosine-kinase inhibitor, chemistry.chemical_compound, 0302 clinical medicine, Piperidines, Antineoplastic Combined Chemotherapy Protocols, Tumor Microenvironment, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Hematology, 3. Good health, Treatment Outcome, 030220 oncology & carcinogenesis, Ibrutinib, medicine.drug, medicine.medical_specialty, Randomization, Paclitaxel, medicine.drug_class, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Adenocarcinoma, Neutropenia, Placebo, Quimioteràpia combinada, 03 medical and health sciences, ibrutinib, Albumins, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Internal medicine, Pàncrees - Càncer - Tractament, medicine, Humans, Adverse effect, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES], business.industry, Adenine, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, Gemcitabine, phase III, Discontinuation, Pancreatic Neoplasms, 030104 developmental biology, chemistry, Avaluació de resultats (Assistència sanitària), business

    وصف الملف: application/pdf; Print-Electronic

  9. 9

    المساهمون: Institut Català de la Salut, [Ramage JK, Friend E, King B] Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK. [Randell J] University of Winchester, Winchester, UK. [Fernandez Ortega P] Institut Catala d’Oncologia, Barcelona, Spain. [McNamara MG] Division of Cancer Sciences, University of Manchester/The Christie NHS Foundation Trust, Manchester, UK. [Capdevila J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    Dipòsit Digital de la UB
    Universidad de Barcelona
    Ramage, J K, Friend, E, Randell, J, King, B, Fernandez Ortega, P, Mcnamara, M G, Kaltsas, G, Falconi, M, Cwikla, J, Capdevila, J, Grozinsky-glasberg, S, Mandair, D, Gamper, E, Srirajaskanthan, R, Weickert, M & Gray, D 2022, ' Development of a Quality of Life Questionnaire for Patients with Pancreatic Neuroendocrine Tumours (the PANNET module) ', Journal of Neuroendocrinology . https://doi.org/10.1111/jne.13097

    وصف الملف: application/pdf

  10. 10

    المساهمون: World Cancer Research Fund International, European Research Council, Unión Europea. Comisión Europea, Federal Ministry of Education & Research (Alemania), Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF), Instituto de Salud Carlos III, Red Temática de Investigación Cooperativa en Cáncer (España), Institut Català de la Salut, [Kartal E, Wirbel J] Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany. Collaboration for joint PhD degree, European Molecular Biology Laboratory and Heidelberg University, Heidelberg, Germany. [Schmidt TSB, Maistrenko OM] Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany. [Molina-Montes E] Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Madrid, Spain. [Rodríguez-Perales S] Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Madrid, Spain. Molecular Cytogenetics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [Molero X] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Repisalud
    Instituto de Salud Carlos III (ISCIII)
    Gut
    Scientia

    وصف الملف: application/pdf